Medicinal chemist are striving to arrive at a promising anti-tubercular agents which can be effective against XDR & MDR tuberculosis. This has made them to work non-conventionally to arrive at promising “Hit”. This article describes synthesis and antimycobacterial activity of clubbed thiazolyl-triazole molecule which are synthesised overriding the Lipinski rule of five. The compounds have shown potency comparable with isoniazid even with 25 XDR & MDR clinical isolates. The candidate is under further development status and is showing promising activity with minimal toxicity.
Select your language of interest to view the total content in your interested language